|
|
Volumn 101, Issue 12, 2000, Pages
|
|
National Heart, Lung, and Blood Institute halts part of antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT)
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT;
CHLORTALIDONE;
DIURETIC AGENT;
DOXAZOSIN;
HYPOCHOLESTEROLEMIC AGENT;
ARTICLE;
CLINICAL TRIAL;
COMPARATIVE STUDY;
CONGESTIVE HEART FAILURE;
FEMALE;
HEALTH CARE ORGANIZATION;
HEART INFARCTION;
HUMAN;
HYPERCHOLESTEROLEMIA;
HYPERTENSION;
MALE;
MIDDLE AGED;
TREATMENT FAILURE;
UNITED STATES;
ADRENERGIC ALPHA-ANTAGONISTS;
ANTICHOLESTEREMIC AGENTS;
CHLORTHALIDONE;
DIURETICS;
DOXAZOSIN;
FEMALE;
HEART FAILURE, CONGESTIVE;
HUMANS;
HYPERCHOLESTEROLEMIA;
HYPERTENSION;
MALE;
MIDDLE AGED;
MYOCARDIAL INFARCTION;
NATIONAL INSTITUTES OF HEALTH (U.S.);
TREATMENT FAILURE;
UNITED STATES;
MLCS;
MLOWN;
|
|
EID: 0034724098
PISSN: None
EISSN: 15244539
Source Type: Journal
DOI: 10.1161/01.cir.101.12.e9025 Document Type: Article |
|
Times cited : (7)
|
|
References (0)
|
